Key Record Dates
ClinicalTrials.gov Identifier: | NCT05483868 |
---|---|
Brief Title: | A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer |
First Submitted : | July 20, 2022 |
First Submitted that Met QC Criteria : | July 29, 2022 |
First Posted : | August 2, 2022 |
Last Update Submitted that Met QC Criteria : | March 2, 2024 |
Last Update Posted : | March 5, 2024 |